Genentech

Genentech, a pioneering biotechnology company founded in 1976, specializes in developing innovative medicines to address serious medical conditions. They generate revenue primarily through the research, development, and commercialization of biopharmaceuticals, including treatments for cancer, autoimmune diseases, and other serious illnesses. Acquired by Roche in 2009, Genentech operates as an independent center within Roche's global research network, maintaining a strong focus on scientific discovery and patient-centric solutions. Their groundbreaking work in recombinant DNA technology has positioned them as leaders in the biotech industry.

Recent Posts by Genentech

1-20 of 2331